Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology


News provided by

COPAN Diagnostics, Inc.

Jan 19, 2022, 11:00 ET

Share this article

Share toX

Share this article

Share toX

MURRIETA, Calif., Jan. 19, 2022 /PRNewswire/ -- On the heels of recent news of FDA clearance for Colibri™, automated colony picking instrument for identification and antimicrobial susceptibility testing in clinical Microbiology, today COPAN announced the North American launch of PhenoMATRIX® TAG, colony selection software which automatically chooses isolated colonies on plated media for picking. This new capability is a major enhancement to PhenoMATRIX® artificial intelligence (AI) software which allows automated specimen processor WASPLab® users to automatically pre-assess and pre-sort culture plates and segregate bacterial cultures.

Continue Reading

COPAN launches PhenoMATRIX® TAG, AI software that automatically selects isolated colonies on plated media for picking.

Post this
PhenoMATRIX® TAG automatically detects and “tags” the best colonies to be picked for specimen workup.  PhenoMATRIX® TAG can interpret growth based on each laboratory’s custom rules, presumptively identify colonial morphology, and pre-select the best isolated colonies for workup.
PhenoMATRIX® TAG automatically detects and “tags” the best colonies to be picked for specimen workup. PhenoMATRIX® TAG can interpret growth based on each laboratory’s custom rules, presumptively identify colonial morphology, and pre-select the best isolated colonies for workup.

PhenoMATRIX® is an unparalleled AI powered software, developed with an advanced selection of highly sophisticated algorithms designed for use in the clinical Microbiology laboratory. By grouping negative cultures, which represent the majority of cultures screened, Microbiologists can quickly review up to 40 plates at a time and batch release negative results quickly. Eliminating the need to review each plate manually, saves precious time and allows technicians to focus on complex cultures which require their unique expertise, and to consult with physicians to provide better patient care. 

The power of PhenoMATRIX® AI is enhanced with PhenoMATRIX® TAG which automatically performs colony selection for ID and AST workup immediately after automated culture interpretation.

"This is truly the next revolution in AI for Clinical Microbiology. PhenoMATRIX® TAG uses advanced algorithms to ensure that the best and most isolated colonies are chosen for workup, every time. This technology brings speed and precision to a task that requires high mental acuity and places a lot of stress on overburdened laboratory technologists. This innovation in laboratory automation rapidly and precisely ensures that the correct isolated and/or pure aggregated colonies are automatically chosen for work-up," said COPAN Diagnostics' CEO Norman Sharples.

PhenoMATRIX® TAG automatically detects and "tags" the best colonies to be picked by Colibri™ for workup. PhenoMATRIX® TAG can interpret growth based on each laboratory's custom rules, presumptively identify colonial morphology, and pre-select the best isolated colonies for workup. The PhenoMATRIX® TAG software highlights isolated colonies as well as aggregated colonies; colonies which are not fully isolated but determined by the software to be identical and thus pure. After defining the optimal colonies for selection, PhenoMATRIX® TAG communicates the colony coordinates to the Colibri™ for reliable and accurate picking. 

COPAN Diagnostics' Workflow Specialist and LEAN Six Sigma Blackbelt, Rosalind Russell discussed the impact that PhenoMATRIX® TAG has on laboratory workflow. "The most critical and technically complex aspect of positive culture workup is the selection and picking of colonies for ID and AST workup. Approximately 30% of all cultures require ID/AST workup and this accounts for more than 50% of technologist time to perform. With PhenoMatrix® TAG and Colibri™, this high complexity task can be managed automatically for up to 70% of positive cultures. These are plates that do not even need to be touched by the technologist. PhenoMATRIX® TAG software uses AI to define optimal colony diameter, degree of isolation and uniformity to reduce errors and standardize this highly complex process. Colibri™ interfaces with the AI to pick the assigned colonies without the need to touch the plate.

About COPAN Laboratory Automation WASPLab®
WASPLab® is a highly efficient, modular, scalable, and customizable specimen processing and culture work-up system for Clinical Microbiology. Samples move from front-end processing to Smart Incubation, Digital Microbiology and Artificial Intelligence/Interpretive Algorithms for plate reading. The system accepts any manufacturer's plated media, and utilizes gold standard, CLSI approved system for planting and streaking.

About Colibri™:

COPAN's Colibri™ automatically picks isolated colonies for further workup and investigations. Colonies are designated by the laboratory technologist or automatically by COPAN's advanced AI, PhenoMATRIX® TAG. Colibri™ works with both VITEK® MS MALDI-TOF and Bruker Biotyper® systems seeding either manufacturers' target plate formats, automatically applying matrix, and through a software interface, sending instructions and coordinates identifying each individual culture workup spot. The precision robotics of the full laboratory automation system WASPLab® combined with Colibri™ help to eliminate any potential transposition errors. Colibri™ can also seed colonies into various size tubes or bottles to prepare McFarland suspensions for antibiotic susceptibility testing (AST)* verifying opacity of suspensions using the onboard nephelometer. The system applies barcode labels to tubes and prepares purity check plates from these suspensions. 

When asked how PhenoMATRIX® TAG and Colibri™ will impact clinical Microbiology, COPAN's Scientific Director and former Directory of Microbiology at Kaiser Permanente, Dr. Susan Sharp said "This technology allows highly skilled technologists to simply and quickly review and release automated culture results and spend their valuable time investigating the most complex cultures of the day. Technologists will have the time to consult with patients' clinicians about the appropriate path for evaluation of these difficult cultures and expediently release these reports."

To learn more about visit www.copanusa.com/phenomatrix.

About COPAN Diagnostics, Inc.

COPAN Diagnostics is part of COPAN Group, a leading manufacturer of collection and transport systems and full laboratory automation in the world. COPAN's collaborative approach to pre-analytics has resulted in FLOQSwabs®, ESwab™, UTM Universal Transport Medium®, laboratory automation including WASP® and WASPLab®. For more information, visit www.copanusa.com.

*AST capability currently IUO (Investigational Use Only) in the USA market. Always consult product inserts and instructions for use for the appropriate use of the products. Product clearance and availability restrictions may apply in some countries.

SOURCE COPAN Diagnostics, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Copan Expands U.S. Manufacturing Footprint with Multimillion-Dollar Investment

Copan Expands U.S. Manufacturing Footprint with Multimillion-Dollar Investment

Copan Diagnostics, part of the privately held Italy-based Copan Group and a leader in specimen collection and transport, and laboratory automation,...

Copan Launches UriVerse™: Fully Automated Solution for Urine Specimen Aliquoting

Copan Launches UriVerse™: Fully Automated Solution for Urine Specimen Aliquoting

Copan, a leader in microbiology laboratory and automation innovations, proudly announced the official launch of UriVerse™ during the Association for...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Pharmaceuticals

Pharmaceuticals

Medical Pharmaceuticals

Medical Pharmaceuticals

Computer Software

Computer Software

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.